Latest On-Demand Webinars & Online Events

In this webinar, our expert speaker Tom Bentivegna will highlight the pipetting best practices that you can implement in your lab for a faster workflow and greater confidence in your results

In this webinar, our expert speakers will explore the vital role of qPCR and digital PCR in supporting advanced therapy medicinal products, including cell therapies. Discover best practices for assay design, validation parameters and acceptance criteria crucial for ensuring the safety and efficacy of cell therapy programs. Learn how molecular precision can safeguard these innovative therapies and drive breakthroughs in the field.

Multiple solutions have been devised to increase multiplexing in qPCR, including single-well techniques, using target-specific fluorescent oligonucleotide probes, and spatial multiplexing, where
segregation of the sample enables parallel amplification of multiple targets.

There is a need for innovations that will push forward the multiplexing field in qPCR, enabling for the next generation of diagnostic tools which could accommodate high throughput in an affordable manner. To this end, the use of machine learning algorithms has recently emerged to leverage information contained in amplification and melting curves– two of the most standard biosignals emitted during qPCR – for accurate classification of multiple nucleic acid targets in a single reaction.

Thermo Fisher Scientific are not affiliated with the webinar speaker. Any application of machine learning technologies with the Diomni™ software package, related assay definition files (ADFs) and related qPCR instruments are for research use only.

With the recent COVID-19 pandemic, quantitative polymerase chain reaction (qPCR) was adopted rapidly into clinical and point-of-care testing laboratories enabling prompt diagnostics, treatment and surveillance. qPCR remains the go-to method for microbial detection in areas including clinical, agricultural, veterinary and food safety diagnostics.

This exclusive Ask Me Anything session delves into the cutting-edge advancements and international policy changes driving sustainability in the laboratory.

This AMA event grants you unprecedented access to the pioneering expert Dr. Nigel Jamieson, delving deep into the captivating realm of spatial biology – completely free of charge.

Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this continue to develop in the next five years?
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.

This exclusive AMA event grants you unprecedented access to the pioneering expert Prof. Michael Snyder a distinguished professor at Stanford University known for his ground-breaking work in digitalizing scientific research in the genomics and personalized medicine field.

When designing molecular diagnostic tests, different parameters are of interest to evaluate, for example, sensitivity, specificity, dynamic range, turnaround time and user friendliness. Which parameters are most important depends on application and may require extensive optimization. Examples will be discussed based on quantitative real-time PCR (qPCR) and digital PCR (dPCR).

The polymerase chain reaction (qPCR) is firmly established as the method of choice for the detection of microbial agents in the areas of clinical, veterinary and agricultural diagnostics and food safety. The current pandemic has highlighted the critical importance of local, fast and specific testing for SARS-CoV-2. It should also act as a wake-up call for the threat posed by infectious diseases spreading because of climate change, increasing antibiotic resistance and the hazard of zoonotic transfer caused by human encroachment of animal habitats. We are working on new tests, protocol and reagents to achieve faster molecular diagnostic testing both for both laboratory based and POC applications. Our target of delivering a diagnostic test result within five minutes of sampling has the potential to lead to a paradigm shift in our approach to detecting and classifying microbial pathogens in preparation for the inevitable next pandemic